241 related articles for article (PubMed ID: 2216456)
1. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
3. p53 abnormalities in different subtypes of human sarcomas.
Andreassen A; Oyjord T; Hovig E; Holm R; Flørenes VA; Nesland JM; Myklebost O; Høie J; Bruland OS; Børresen AL
Cancer Res; 1993 Feb; 53(3):468-71. PubMed ID: 8425179
[TBL] [Abstract][Full Text] [Related]
4. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
5. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
[TBL] [Abstract][Full Text] [Related]
6. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.
Brachman DG; Hallahan DE; Beckett MA; Yandell DW; Weichselbaum RR
Cancer Res; 1991 Dec; 51(23 Pt 1):6393-6. PubMed ID: 1933904
[TBL] [Abstract][Full Text] [Related]
8. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami Y; Hayashi K; Hirohashi S; Sekiya T
Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
[TBL] [Abstract][Full Text] [Related]
9. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.
Ruggeri B; Zhang SY; Caamano J; DiRado M; Flynn SD; Klein-Szanto AJ
Oncogene; 1992 Aug; 7(8):1503-11. PubMed ID: 1630814
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours.
Nawa G; Miyoshi Y; Yoshikawa H; Ochi T; Nakamura Y
Br J Cancer; 1999 Jun; 80(8):1185-9. PubMed ID: 10376970
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
Corradini P; Inghirami G; Astolfi M; Ladetto M; Voena C; Ballerini P; Gu W; Nilsson K; Knowles DM; Boccadoro M
Leukemia; 1994 May; 8(5):758-67. PubMed ID: 8182933
[TBL] [Abstract][Full Text] [Related]
12. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of p53 and p110RB tumor suppressor gene expression in human soft tissue tumors: correlations with cell proliferation and tumor grade.
Wang J; Coltrera MD; Gown AM
Mod Pathol; 1995 Oct; 8(8):837-42. PubMed ID: 8552572
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic considerations in osteosarcoma.
Hansen MF
Clin Orthop Relat Res; 1991 Sep; (270):237-46. PubMed ID: 1679382
[TBL] [Abstract][Full Text] [Related]
15. Studies of the RB1 gene and the p53 gene in human osteosarcomas.
Scholz RB; Kabisch H; Weber B; Röser K; Delling G; Winkler K
Pediatr Hematol Oncol; 1992; 9(2):125-37. PubMed ID: 1524989
[TBL] [Abstract][Full Text] [Related]
16. Mutation of the p53 gene in postradiation sarcoma.
Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
[TBL] [Abstract][Full Text] [Related]
17. p53 expression, mutation, and allelic deletion in ovarian cancer.
McManus DT; Yap EP; Maxwell P; Russell SE; Toner PG; McGee JO
J Pathol; 1994 Nov; 174(3):159-68. PubMed ID: 7823248
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.
Cote RJ; Jhanwar SC; Novick S; Pellicer A
Cancer Res; 1991 Oct; 51(19):5410-6. PubMed ID: 1913660
[TBL] [Abstract][Full Text] [Related]
19. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
20. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients.
Yoo J; Robinson RA
Cancer; 1999 Jul; 86(1):58-63. PubMed ID: 10391564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
